×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Evoke Pharma, Inc. (NASDAQ:EVOK): Are Analysts Optimistic?
Yahoo Finance
According to some industry analysts covering Evoke Pharma, breakeven is near. They expect the company to post a final loss in 2025, before...
2 months ago
Evoke Pharma Announces Closing of $7.5 Million Public Offering
GlobeNewswire
Evoke Pharma Announces Closing of $7.5 Million Public Offering · Potential for Additional $22.5 Million in the Event of Exercise of Common...
3 months ago
Evoke Pharma Announces Senior Leadership Transition with Promotion of Matthew J. D'Onofrio to Chief Executive Officer
Yahoo Finance
“Working closely with Dave has been an absolute privilege,” said Matt D'Onofrio, incoming Chief Executive Officer of Evoke Pharma. “His...
2 months ago
Evoke Pharma Announces Executive Changes and Expansion Plans - TipRanks.com
Tipranks
Evoke Pharma (EVOK) has provided an announcement. Evoke Pharma, Inc. has seen pivotal developments, including the appointment of Mark A. Kowieski as CFO,...
2 weeks ago
EVOK Stock Earnings: Evoke Pharma Beats EPS, Misses Revenue for Q1 2024
InvestorPlace
EVOK Stock Earnings: Evoke Pharma Beats EPS, Misses Revenue for Q1 2024 · Evoke Pharma reported earnings per share of -17 cents. This was above...
1 month ago
StockNews.com Initiates Coverage on Evoke Pharma (NASDAQ:EVOK)
Defense World
Research analysts at StockNews.com began coverage on shares of Evoke Pharma (NASDAQ:EVOK – Get Free Report) in a research report issued on...
1 week ago
Evoke conjures up new branding, adopting tweaked name and structure in simplification push
Fierce Pharma
Evoke conjures up new branding, adopting tweaked name and structure in simplification push ... Evoke has marked the new year with a new name. The...
5 months ago
Evoke Pharma Announces Pricing of Underwritten Public Offering of up to $30 Million
GlobeNewswire
EVOK Logo.jpg · Evoke Pharma Announces Pricing of Underwritten Public Offering of up to $30 Million. February 09, 2024 07:30 ET...
4 months ago
Evoke Pharma, Inc. (NASDAQ:EVOK) Short Interest Up 6.0% in May
Defense World
Read Evoke Pharma, Inc. (NASDAQ:EVOK) Short Interest Up 6.0% in May at Defense World.
1 week ago
Evoke Pharma Reports First Quarter 2024 Financial Results
Yahoo Finance
114% year-over-year increase in net product sales70% prescriber growth in Q1 2024 compared to Q4 2023Growing sales metrics reaffirms...
1 month ago